General Catalyst Group Management, Llc Portfolio Stock Holdings

According to the SEC 13F filed on August 17, 2026, General Catalyst Group Management, Llc disclosed 14 stock positions valued at approximately $188.52M as of quarter-end June 30, 2026. The largest holdings include ArriVent BioPharma, Inc., Parabilis Medicines, Inc., and Maplebear, Inc..

Report Period
June 30, 2026
No. of Stocks
14
Portfolio Value
$188.52M
Holdings by Sector
General Catalyst Group Management, Llc Portfolio Holdings in Q2 2026
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
ArriVent BioPharma, Inc. AVBPHealthcare27.55%1,494,786--$51,928,866
Parabilis Medicines, Inc.PBLSOther23.24%1,600,937+1,600,937+100.00%$43,817,646
Maplebear, Inc. CARTConsumer Cyclical17.85%710,711--$33,652,166
Maze Therapeutics, Inc. MAZEOther16.40%1,035,910--$30,911,554
Odyssey Therapeutics, Inc. ODTXOther8.04%810,272+810,272+100.00%$15,160,189
Eikon Therapeutics, Inc. EIKNOther2.11%305,233--$3,983,291
Fractyl Health, Inc. GUTSHealthcare2.06%4,884,186-7-0.00%$3,879,997
Ethos Technologies, Inc.LIFEOther0.71%74,179--$1,345,607
Coupang Inc. CPNGConsumer Cyclical0.50%54,677+18,000+49.08%$949,739
Amazon.com Inc.AMZNConsumer Cyclical0.49%3,882+1,300+50.35%$925,236
Meta Platforms Inc. METACommunication Services0.39%1,320+662+100.61%$743,543
Doordash Inc. DASHCommunication Services0.28%2,850+2,850+100.00%$525,911
Carvana CoCVNAConsumer Cyclical0.23%6,465+6,465+100.00%$425,526
Figma, Inc. FIGOther0.14%14,845--$268,546
Showing 14 of 14 holdings in the latest reporting period.